Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-12T09:25:51.706Z Has data issue: false hasContentIssue false

Improving Blood Culture Pathogen Detection, Reducing Contamination, and Timeliness in the Emergency Department

Published online by Cambridge University Press:  23 June 2026

Debby Ben David
Affiliation:
Wolfson Medical Center
Yael Cohen
Affiliation:
wolfson medical center
Andrey Chopen
Affiliation:
Wolfson medical center

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Background Blood cultures obtained in the emergency department (ED) are critical for diagnosing bloodstream infections but are frequently compromised by suboptimal sampling practices, contamination, and delays in transport to the microbiology laboratory. These limitations reduce diagnostic yield and may contribute to inappropriate antibiotic use. We evaluated the impact of a sustained, multicomponent quality-improvement intervention on blood culture quality, diagnostic yield, timeliness of transport to the microbiology laboratory, and time to culture growth. Methods We conducted a retrospective analysis of all blood cultures obtained in the ED of an acute-care hospital between January 2019 and December 2025. The ED treats approximately 85,000 patients annually. A multicomponent intervention was initiated in January 2021 and included repeated staff education, quarterly performance feedback, and workflow optimization. Blood culture transport was transitioned from manual delivery to a pneumatic tube system, and diversion tubes were introduced in January 2023 to decrease contamination. Outcomes included annual uptake of two-set sampling, pathogen detection, and contamination rates. Time from collection to incubation and growth was evaluated before and after the intervention. Trends across years were assessed using a test for linear trend. Results A total of 10,729 blood cultures were analyzed. Adoption of two-set blood culture sampling increased over time, from <3.2% (33/901) in 2019 to 45.9% (904/1,971) in 2025 (p<0.001; Figure 1). Overall, the proportion of blood cultures yielding a pathogen increased during the study period, rising from 6.8% (61/901) in 2019 to 12.2% (240/1,971) in 2025 (p for trend <0.001). Pathogen detection was significantly higher when two blood culture sets were obtained compared with a single set (12.9% [455/3,532] vs 8.8% [634/7,197]; p<0.001). In parallel, contamination rates declined markedly, from 13.9% (130/935) in 2019 to 6.0% (173/2,894) in 2025 (Figure 2). Among positive blood cultures, the distribution shifted over time, with contaminants predominating early and true pathogens predominating during the intervention period. (Figure 3) Timeliness of blood culture handling improved concurrently. Median time from collection to laboratory arrival decreased from 9.4 hours (IQR 2.8–14.9) to 2.3 hours (IQR 1.3–4.0; p<0.001). Concurrently, median time from collection to culture growth decreased from 27.7 hours (IQR 20.4–38.5) to 20.0 hours (IQR 14.6–29.3; p<0.001). Conclusions A sustained, multicomponent quality-improvement intervention in the ED was associated with improved blood culture diagnostic yield, reduced contamination, shorter laboratory processing times, and earlier growth detection. These findings highlight the value of coordinated process optimization to advance diagnostic stewardship and patient safety in high-acuity settings.

A bar graph showing trends in two-set blood culture sampling and pathogen detection from 2019 to 2025.

A bar graph showing trends in blood culture contamination from 2019 to 2025.

A bar graph showing the yearly distributions of pathogens versus contaminants among positive blood cultures from 2019 to 2025.

Information

Type
Diagnostic Stewardship
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America